Clinical Trial Update: Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica [Phase 3]

View source ↗

Summary

A Phase 3 trial to justify and evaluate whether adding baricitinib to corticosteroids improves outcomes versus corticosteroids alone in polymyalgia rheumatica; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Baricitinib (baricitinib)
• Corticosteroids (corticosteroids)

Snippet

Sponsor: University Hospital, Brest | Conditions: Polymyalgia Rheumatica (PMR) | Phase 3 | Status: NOT_YET_RECRUITING